Sun Jian David Acquires Shares in 111, Inc.
Sun Jian David purchased 18,366 shares of 111, Inc. on September 12, 2018.
Key Points
- Sun Jian David acquired 18,366 shares of 111, Inc. (YI) on September 12, 2018, as part of insider transactions.
- Shares of 111, Inc. traded at $4.57 with a market cap of approximately $40.2 million and a forward P/E ratio of 32.64.
- Institutional activity includes Renaissance Technologies increasing its holdings to 13,014 shares, while UBS Group AG decreased its position.
Sun Jian David made a notable purchase of 18,366 shares in 111, Inc. (NasdaqGM: YI) on September 12, 2018. This insider transaction was not part of a pre-planned trading program.
Other Institutional Activity in 111, Inc.
In addition to insider purchases, several institutional investors have adjusted their positions in 111, Inc. Renaissance Technologies LLC added 300 shares, bringing its total to 13,014 shares valued at about $84,851. Serenus Wealth Advisors, LLC slightly reduced its holdings by 64 shares, ending with 4,320 shares worth approximately $321,334. Citigroup Inc. acquired 207 shares, matching its total share count, while UBS Group AG reduced its stake by 203 shares, leaving it with 100 shares valued at $652.
111, Inc. Stock Snapshot
Shares of 111, Inc. traded at $4.57, with a market capitalization of roughly $40.2 million. The company has a forward P/E ratio of 32.64, indicating expectations of future profitability. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company maintains a current ratio of 1.08 and a quick ratio of 0.37, with a debt-to-equity ratio of 150.93.
Insider Buying and Selling at 111, Inc.
Recent insider activity at 111, Inc. shows Sun Jian David selling shares on several occasions in June 2026, including 58,800 shares on June 15 and 111,100 shares on June 11, all at an average price of $0.23. Similarly, Chen Yang Luke sold 44,000 shares on June 15 and 49,920 shares on June 12, each at the same average price.
About 111, Inc.
111, Inc. is a healthcare company based in Shanghai, China. It operates an integrated online and offline platform through its B2C and B2B segments. The company offers a wide range of services, including supply chain integration, product promotion, and online retail pharmacy services. It also provides online consultation, e-prescription, and data services. Founded in 2010, 111, Inc. aims to enhance the efficiency of healthcare distribution in China, serving pharmacies, pharmaceutical companies, and medical professionals.
Bottom Line
Sun Jian David's acquisition of 18,366 shares in 111, Inc. highlights ongoing interest in the company. While insider transactions can provide insights, they are only one piece of the puzzle for investors. The stock's recent performance, institutional activity, and market conditions are all factors to consider. As always, it's important to remember that insider trading reports are historical and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.